Oxford Sciences Innovation plc (OSI)

https://www.oxfordsciencesinnovation.com

LinkedIn: https://www.linkedin.com/company/oxford-sciences-innovation-plc

Oxford Sciences Innovation (OSI) is a leading science and technology business. OSI ensures Oxford’s world-leading science moves out of the laboratory and onto the global stage. In partnership with the University of Oxford, OSI creates fundamental technology companies, built on science. We match scientists with experienced entrepreneurs and patient capital to turn idea to impact, discovery to company. OSI invests in Life Sciences, Deep Tech, Healthtech, AI and Software to create companies taking on challenges like diagnosis and treatment of disease and cancer, hyper resolution microscopy, renewable energy, drones, nuclear fusion and quantum computing. Founded in 2015, we’ve raised over $800M of evergreen capital, building on Oxford’s renowned research legacy, to create a leading science and technology ecosystem and home for entrepreneurs. OSI backs companies from their inception and invest for the long-term, helping them to build their businesses by finding senior management talent, entrepreneurs, expert advisors and global investors to realise their vision. OSI reinvests any returns back into the Oxford ecosystem and the next generation of scientists and technologies to create even more companies capable of tackling more of the world’s most important problems. *

	Start	2015-05-01 established
	End	2022-03-31 renamed before
	Group	Oxford Science Enterprises (Group)
	Today	Oxford Science Enterprises plc
	Successor	Oxford Science Enterprises plc
	Industry	IP services
	Industry 2	venture capital
	Person	Dormandy, Alexis (Univ Oxford 202108 CEO of OSI)
	Person 2	McLean, Andrew (Univ Oxford 201906 Head of Life Sciences 201712 Principal at Oxford Sciences Innovation)

	Region	Oxford, Oxfordshire
	Country	United Kingdom (GB)
	Street	46 Woodstock Road
	City	OX2 6HT Oxford, Oxfordshire
		Address record changed: 2024-01-05

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	800,000,000 (capital, evergreen (2020) 2020-12-09)

		* Document for »About Section«: PepGen Ltd.. (12/9/20). "Press Release: PepGen Raises $45M Series A". Boston, MA & Oxford.

		Record changed: 2022-12-29